Greenleaf Trust Pfizer Inc Transaction History

Greenleaf Trust

$11.2 Billion
Q3 2024

A detailed history of Greenleaf Trust transactions in Pfizer Inc stock. As of the latest transaction made, Greenleaf Trust holds 297,265 shares of PFE stock, worth $7.95 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

297,265

Previous 285,330 4.18%

Holding current value

$7.95 Million

Previous $7.98 Million 7.75%

% of portfolio

0.08%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$27.7 - $31.39 $330,599 - $374,639	11,935 Added 4.18%	297,265 $8.6 Million
Q2 2024 Jul 22, 2024	BUY	$25.26 - $29.6 $748,908 - $877,580	29,648 Added 11.6%	285,330 $7.98 Million
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $274,641 - $315,375	-10,608 Reduced 3.98%	255,682 $7.1 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $1.08 Million - $1.4 Million	-41,316 Reduced 13.43%	266,290 $7.67 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $422,978 - $494,419	-13,181 Reduced 4.11%	307,606 $10.2 Million
Q2 2023 Aug 09, 2023	BUY	$36.12 - $41.79 $56,491 - $65,359	1,564 Added 0.49%	320,787 $11.8 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $146,136 - $190,248	3,710 Added 1.18%	319,223 $13 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $630,550 - $823,113	15,103 Added 5.03%	315,513 $16.2 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $170,751 - $208,444	3,902 Added 1.32%	300,410 $13.1 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $1.38 Million - $1.64 Million	29,755 Added 11.15%	296,508 $15.5 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $90,996 - $112,756	1,989 Added 0.75%	266,753 $13.8 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $397,705 - $589,531	9,625 Added 3.77%	264,764 $15.6 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $698,296 - $897,022	-17,791 Reduced 6.52%	255,139 $11 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $611,224 - $692,414	17,021 Added 6.65%	272,930 $10.7 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $53,818 - $60,696	-1,607 Reduced 0.62%	255,909 $9.27 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $639,745 - $813,491	19,114 Added 8.02%	257,516 $9.48 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $158,273 - $185,691	4,985 Added 2.14%	238,402 $8.75 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $393,367 - $477,212	13,060 Added 5.93%	233,417 $7.63 Million
Q1 2020 Apr 29, 2020	SELL	$27.03 - $38.62 $368,905 - $527,085	-13,648 Reduced 5.83%	220,357 $7.19 Million
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $86,118 - $97,733	-2,616 Reduced 1.11%	234,005 $9.17 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $530,919 - $688,446	-16,341 Reduced 6.46%	236,621 $8.5 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $62,496 - $70,168	1,690 Added 0.67%	252,962 $11 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $344,212 - $378,174	-9,179 Reduced 3.52%	251,272 $10.7 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $366,811 - $418,205	9,535 Added 3.8%	260,451 $11.4 Million
Q3 2018 Oct 29, 2018	BUY	$34.47 - $41.81 $853,132 - $1.03 Million	24,750 Added 10.94%	250,916 $11.1 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $483,091 - $515,023	14,648 Added 6.93%	226,166 $8.21 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $85,774 - $99,509	2,688 Added 1.29%	211,518 $7.51 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $205,280 - $217,809	6,172 Added 3.05%	208,830 $7.56 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $6.28 Million - $6.92 Million	202,658	202,658 $7.24 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.

Account